BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1708220)

  • 1. Expression of polymorphic HLA-A,B epitopes in human urothelial cell lines.
    Ottesen SS; Kieler J
    Anticancer Res; 1991; 11(1):217-23. PubMed ID: 1708220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identity of non-malignant human urothelial cell lines classified as transformation grade I (TGrI) and II (TGrII).
    Christensen B; Hansen C; Kieler J; Schmidt J
    Anticancer Res; 1993; 13(6A):2187-91. PubMed ID: 7905254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced HLA-A,B,C expression in tumourigenic v-raf transfected human urothelial cells.
    Ottesen SS; Skouv J; Kieler J
    Eur J Cancer; 1990 Mar; 26(3):305-10. PubMed ID: 2141486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of selective human leukocyte antigen (HLA)-A and HLA-B epitope losses in early-passage tumor cell lines.
    Giacomini P; Giorda E; Fraioli R; Nicotra MR; Vitale N; Setini A; Delfino L; Morabito A; Benevolo M; Venturo I; Mottolese M; Ferrara GB; Natali PG
    Cancer Res; 1999 Jun; 59(11):2657-67. PubMed ID: 10363989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines.
    Ottesen SS; Ahrenkiel V; Kieler J
    Cancer Immunol Immunother; 1990; 31(2):93-8. PubMed ID: 2108803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
    Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
    Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between classification of human urothelial cell lines and HLA-A,B,C expression.
    Ottesen SS; Tromholt V; Kieler J
    Cancer Immunol Immunother; 1988; 26(1):83-6. PubMed ID: 3278802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma.
    Momburg F; Ziegler A; Harpprecht J; Möller P; Moldenhauer G; Hämmerling GJ
    J Immunol; 1989 Jan; 142(1):352-8. PubMed ID: 2462591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
    Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
    Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
    El-Awar NR; Akaza T; Terasaki PI; Nguyen A
    Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line.
    Shimizu Y; DeMars R
    J Immunol; 1989 May; 142(9):3320-8. PubMed ID: 2785140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HLA-A2 antigen in human melanoma cell lines and its role in T-cell recognition.
    Pandolfi F; Boyle LA; Trentin L; Kurnick JT; Isselbacher KJ; Gattoni-Celli S
    Cancer Res; 1991 Jun; 51(12):3164-70. PubMed ID: 1904004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy.
    Carlsson B; Forsberg O; Bengtsson M; Tötterman TH; Essand M
    Prostate; 2007 Mar; 67(4):389-95. PubMed ID: 17219382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype loss of HLA class I antigen as an escape mechanism from immune attack in lung cancer.
    So T; Takenoyama M; Mizukami M; Ichiki Y; Sugaya M; Hanagiri T; Sugio K; Yasumoto K
    Cancer Res; 2005 Jul; 65(13):5945-52. PubMed ID: 15994973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential analysis of monomorphic and polymorphic major histocompatibility complex antigen expression in human heart allograft biopsy specimens.
    Steinhoff G; Wonigeit K; Schäfers HJ; Haverich A
    J Heart Transplant; 1989; 8(5):360-70. PubMed ID: 2552061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in HLA A, B, C expression during "spontaneous" transformation of human urothelial cells in vivo.
    Ottesen SS; Kieler J; Christensen B
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):991-5. PubMed ID: 3499328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I epitopes: A and B loci.
    El-Awar N; Cook D; Terasaki PI
    Clin Transpl; 2006; ():79-94. PubMed ID: 18365370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.